Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Star Combo Pharma Ltd. ( (AU:S66) ) has provided an update.
Star Combo Pharma Ltd reported a significant increase in profit after tax to $5.25 million for the financial year ending June 30, 2025, attributed to strong revenue growth and the settlement of an insurance claim. The company declared its second dividend, reflecting confidence in its business stability, and anticipates further production capacity expansion by the end of FY2026, indicating a positive outlook for the future.
More about Star Combo Pharma Ltd.
Star Combo Pharma Ltd is a Sydney-based contract manufacturer specializing in vitamins, health, and beauty products, with a focus on natural ingredients and scientific R&D. The company supplies products through the Australian pharmacy network and wholesale customers in Australia, Vietnam, and China, aiming to be a leading manufacturer of premium vitamins and dietary supplements.
Average Trading Volume: 20,203
Technical Sentiment Signal: Buy
Current Market Cap: A$22.95M
For a thorough assessment of S66 stock, go to TipRanks’ Stock Analysis page.